[e-mail]

Medivation's Attitude Warrants a Pullback

The data was published, In the Lancet no less, so I'm not sure what you're talking about:

biz.yahoo.com/prnews/0...

<<<Specifical... the company failed to deliver on the publication of Phase II trial data it had promised investors.>>>

All that matters is hitting their primary endpoint. That its not disease modifying or reversing is completely irrelevant.